Recombinant Vaccines Market Size, Share, And Growth Report 2032
Recombinant Vaccines Market By Product (Attenuated, Vector, and Subunit), By Application (Veterinary and Human), By Disease (Hepatitis B, Cancer, Influenza, and Others), By Distribution Channel (Hospitals, Clinics, Veterinary Clinics, Retail Pharmacies, and Others), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 10.15 Billion | USD 26.61 Billion | 11.3% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Recombinant Vaccines Market, 2016-2025 (USD Million)
- 2.2. Global Recombinant Vaccines Market: Snapshot
- Chapter 3. Recombinant Vaccines Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Safe to use nature of recombinant vaccines
- 3.2.2. High investment by recombinant vaccine manufacturers for the development of novel products
- 3.3. Market restraints
- 3.3.1. Risk related to the use of attenuated vaccines
- 3.3.2. The high cost of recombinant vaccines
- 3.4. Opportunities
- 3.4.1. Rising awareness regarding recombinant vaccines benefits in developing regions
- 3.4.2. Rising per capita healthcare expenditure
- 3.5. Porter's Five Forces Analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Type
- 3.6.2. Market attractiveness analysis, by Application
- 3.6.3. Market attractiveness analysis, by Disease
- 3.6.4. Market attractiveness analysis, by Distribution Channel
- 3.6.5. Market attractiveness analysis, by Region
- Chapter 4. Global Recombinant Vaccines Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Recombinant Vaccines market: company Market Share, 2019
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Product Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. Research and Development and Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Recombinant Vaccines Market - Type Analysis
- 5.1. Global Recombinant Vaccines Market: Type overview
- 5.1.1. Global Recombinant Vaccines Market Share, by Type, 2018 and 2025
- 5.2. Attenuated
- 5.2.1. Global Recombinant Vaccines Market for Attenuated, 2016-2025 (USD Million)
- 5.3. Vector
- 5.3.1. Global Recombinant Vaccines Market for Vector, 2016-2025 (USD Million)
- 5.4. Subunit
- 5.4.1. Global Recombinant Vaccines Market for Subunit, 2016-2025 (USD Million)
- 5.1. Global Recombinant Vaccines Market: Type overview
- Chapter 6. Global Recombinant Vaccines Market - Application Analysis
- 6.1. Global Recombinant Vaccines Market: Application overview
- 6.1.1. Global Recombinant Vaccines Market Share, by Application, 2018 and 2025
- 6.2. Veterinary
- 6.2.1. Global Recombinant Vaccines Market for Veterinary, 2016-2025 (USD Million)
- 6.3. Human
- 6.3.1. Global Recombinant Vaccines Market for Human, 2016-2025 (USD Million)
- 6.1. Global Recombinant Vaccines Market: Application overview
- Chapter 7. Global Recombinant Vaccines Market - Disease Analysis
- 7.1. Global Recombinant Vaccines Market: Disease overview
- 7.1.1. Global Recombinant Vaccines Market Share, by Disease, 2018 and 2025
- 7.2. Hepatitis B
- 7.2.1. Global Recombinant Vaccines Market for Hepatitis B, 2016-2025 (USD Million)
- 7.3. Cancer
- 7.3.1. Global Recombinant Vaccines Market for Cancer, 2016-2025 (USD Million)
- 7.4. Influenza
- 7.4.1. Global Recombinant Vaccines Market for Influenza, 2016-2025 (USD Million)
- 7.5. Others
- 7.5.1. Global Recombinant Vaccines Market for Others, 2016-2025 (USD Million)
- 7.1. Global Recombinant Vaccines Market: Disease overview
- Chapter 8. Global Recombinant Vaccines Market - Distribution Channel Analysis
- 8.1. Global Recombinant Vaccines Market: Distribution Channel overview
- 8.1.1. Global Recombinant Vaccines Market Share, by Distribution Channel, 2018 and 2025
- 8.2. Hospitals
- 8.2.1. Global Recombinant Vaccines Market for Hospitals, 2016-2025 (USD Million)
- 8.3. Clinics
- 8.3.1. Global Recombinant Vaccines Market for Clinics, 2016-2025 (USD Million)
- 8.4. Veterinary Clinics
- 8.4.1. Global Recombinant Vaccines Market for Veterinary Clinics, 2016-2025 (USD Million)
- 8.5. Retail Pharmacies
- 8.5.1. Global Recombinant Vaccines Market for Retail Pharmacies, 2016-2025 (USD Million)
- 8.6. Others
- 8.6.1. Global Recombinant Vaccines Market for Others, 2016-2025 (USD Million)
- 8.1. Global Recombinant Vaccines Market: Distribution Channel overview
- Chapter 9. Global Recombinant Vaccines Market - Regional Analysis
- 9.1. Global Recombinant Vaccines Market: Regional overview
- 9.1.1. Global Recombinant Vaccines Market Share, by region, 2018 and 2025
- 9.2. North America
- 9.2.1. North America Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.2.2. North America Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.2.3. North America Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.2.4. North America Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.2.5. The U.S.
- 9.2.5.1. The U.S. Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.2.5.2. The U.S. Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.2.5.3. The U.S. Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.2.5.4. The U.S. Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.2.6. Rest of North America
- 9.2.6.1. Rest of North America Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.2.6.2. Rest of North America Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.2.6.3. Rest of North America Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.2.6.4. Rest of North America Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.3. Europe
- 9.3.1. Europe Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.3.2. Europe Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.3.3. Europe Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.3.4. Europe Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.3.5. Germany
- 9.3.5.1. Germany Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.3.5.2. Germany Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.3.5.3. Germany Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.3.5.4. Germany Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.3.6. The U.K.
- 9.3.6.1. U.K. Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.3.6.2. U.K. Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.3.6.3. U.K. Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.3.6.4. U.K. Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.3.7. France
- 9.3.7.1. France Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.3.7.2. France Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.3.7.3. France Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.3.7.4. France Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.3.8. Rest of Europe
- 9.3.8.1. Rest of Europe Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.3.8.2. Rest of Europe Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.3.8.3. Rest of Europe Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.3.8.4. Rest of Europe Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.4.2. Asia Pacific Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.4.3. Asia Pacific Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.4.4. Asia Pacific Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.4.5. China
- 9.4.5.1. China Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.4.5.2. China Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.4.5.3. China Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.4.5.4. China Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.4.6. Japan
- 9.4.6.1. Japan Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.4.6.2. Japan Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.4.6.3. Japan Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.4.6.4. Japan Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.4.7. India
- 9.4.7.1. India Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.4.7.2. India Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.4.7.3. India Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.4.7.4. India Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.4.8. Rest of Asia Pacific
- 9.4.8.1. Rest of Asia Pacific Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.4.8.2. Rest of Asia Pacific Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.4.8.3. Rest of Asia Pacific Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.4.8.4. Rest of Asia Pacific Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.5. Latin America
- 9.5.1. Latin America Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.5.2. Latin America Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.5.3. Latin America Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.5.4. Latin America Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.5.5. Brazil
- 9.5.5.1. Brazil Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.5.5.2. Brazil Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.5.5.3. Brazil Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.5.5.4. Brazil Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.5.6. Rest of Latin America
- 9.5.6.1. Rest of Latin America Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.5.6.2. Rest of Latin America Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.5.6.3. Rest of Latin America Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.5.6.4. Rest of Latin America Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.6. The Middle East and Africa
- 9.6.1. The Middle East and Africa Recombinant Vaccines Market Revenue, by Type, 2016-2025 (USD Million)
- 9.6.2. The Middle East and Africa Recombinant Vaccines Market Revenue, by Application, 2016-2025 (USD Million)
- 9.6.3. The Middle East and Africa Recombinant Vaccines Market Revenue, by Disease, 2016-2025 (USD Million)
- 9.6.4. The Middle East and Africa Recombinant Vaccines Market Revenue, by Distribution Channel, 2016-2025 (USD Million)
- 9.1. Global Recombinant Vaccines Market: Regional overview
- Chapter 10. Company Profile
- 10.1. Pfizer
- 10.1.1. Overview
- 10.1.2. Financials
- 10.1.3. Disease portfolio
- 10.1.4. Business strategy
- 10.1.5. Recent developments
- 10.2. Merck
- 10.2.1. Overview
- 10.2.2. Financials
- 10.2.3. Disease portfolio
- 10.2.4. Business strategy
- 10.2.5. Recent developments
- 10.3. Sanofi Pasteur
- 10.3.1. Overview
- 10.3.2. Financials
- 10.3.3. Disease portfolio
- 10.3.4. Business strategy
- 10.3.5. Recent developments
- 10.4. Bayer
- 10.4.1. Overview
- 10.4.2. Financials
- 10.4.3. Disease portfolio
- 10.4.4. Business strategy
- 10.4.5. Recent developments
- 10.5. GlaxoSmithKline
- 10.5.1. Overview
- 10.5.2. Financials
- 10.5.3. Disease portfolio
- 10.5.4. Business strategy
- 10.5.5. Recent developments
- 10.6. Serum Institute of India
- 10.6.1. Overview
- 10.6.2. Financials
- 10.6.3. Disease portfolio
- 10.6.4. Business strategy
- 10.6.5. Recent developments
- 10.7. Abiomed
- 10.7.1. Overview
- 10.7.2. Financials
- 10.7.3. Disease portfolio
- 10.7.4. Business strategy
- 10.7.5. Recent developments
- 10.8. Johnson & Johnson
- 10.8.1. Overview
- 10.8.2. Financials
- 10.8.3. Disease portfolio
- 10.8.4. Business strategy
- 10.8.5. Recent developments
- 10.9. Emergent Bio Solutions
- 10.9.1. Overview
- 10.9.2. Financials
- 10.9.3. Disease portfolio
- 10.9.4. Business strategy
- 10.9.5. Recent developments
- 10.10. Mitsubishi Tanabe Pharma
- 10.10.1. Overview
- 10.10.2. Financials
- 10.10.3. Disease portfolio
- 10.10.4. Business strategy
- 10.10.5. Recent developments
- 10.1. Pfizer
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Recombinant Vaccines Market Revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Recombinant Vaccines Market attractiveness analysis, by Type
6. Recombinant Vaccines Market attractiveness analysis, by Application
7. Recombinant Vaccines Market attractiveness analysis, by Disease segment
8. Recombinant Vaccines Market attractiveness analysis, by Distribution Channel
9. Recombinant Vaccines: Market attractiveness analysis, by Region
10. Company market share analysis, 2018
11. Global Recombinant Vaccines Market Share by Type, 2018 and 2025
12. Global Recombinant Vaccines Market for Attenuated, 2016–2025 (USD Million)
13. Global Recombinant Vaccines Market for Vector, 2016–2025 (USD Million)
14. Global Recombinant Vaccines Market for Subunit, 2016–2025 (USD Million)
15. Global Recombinant Vaccines Market Share by Application, 2018 and 2025
16. Global Recombinant Vaccines Market for Veterinary, 2016–2025 (USD Million)
17. Global Recombinant Vaccines Market for Human, 2016–2025 (USD Million)
18. Global Recombinant Vaccines Market Share by Disease, 2018 and 2025
19. Global Recombinant Vaccines Market for Hepatitis B, 2016–2025 (USD Million)
20. Global Recombinant Vaccines Market for Cancer, 2016–2025 (USD Million)
21. Global Recombinant Vaccines Market for Influenza, 2016–2025 (USD Million)
22. Global Recombinant Vaccines Market for Others, 2016–2025 (USD Million)
23. Global Recombinant Vaccines Market for Distribution Channel, 2016–2025 (USD Million)
24. Global Recombinant Vaccines Market for Hospitals, 2016–2025 (USD Million)
25. Global Recombinant Vaccines Market for Clinics, 2016–2025 (USD Million)
26. Global Recombinant Vaccines Market for Veterinary Clinics, 2016–2025 (USD Million)
27. Global Recombinant Vaccines Market for Retail Pharmacies, 2016–2025 (USD Million)
28. Global Recombinant Vaccines Market for Others, 2016–2025 (USD Million)
29. North America Recombinant Vaccines Market, 2016–2025 (USD Million)
30. Europe Recombinant Vaccines market, 2016–2025 (USD Million)
31. Asia Pacific Recombinant Vaccines Market, 2016–2025 (USD Million)
32. Latin America Recombinant Vaccines Market, 2016–2025 (USD Million)
33. The Middle East and Africa Recombinant Vaccines Market, 2016–2025 (USD Million)
Table Of Tables
List of Tables
1. Recombinant Vaccines Market: Snapshot
2. Drivers of the global Recombinant Vaccines Market: Impact analysis
3. Restraints of the global Recombinant Vaccines Market: Impact analysis
4. North America Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
5. North America Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
6. North America Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
7. North America Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
8. The U.S. Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
9. The U.S. Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
10. The U.S. Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
11. The U.S. Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
12. Rest of North America Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
13. Rest of North America Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
14. Rest of North America Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
15. Rest of North America Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
16. Europe Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
17. Europe Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
18. Europe Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
19. Europe Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
20. Germany Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
21. Germany Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
22. Germany Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
23. Germany Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
24. U.K. Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
25. U.K. Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
26. U.K. Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
27. U.K. Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
28. France Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
29. France Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
30. France Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
31. France Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
32. Rest of Europe Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
33. Rest of Europe Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
34. Rest of Europe Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
35. Rest of Europe Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
36. Asia Pacific Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
37. Asia Pacific Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
38. Asia Pacific Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
39. Asia Pacific Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
40. China Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
41. China Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
42. China Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
43. China Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
44. Japan Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
45. Japan Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
46. Japan Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
47. Japan Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
48. India Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
49. India Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
50. India Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
51. India Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
52. Rest of Asia Pacific Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
53. Rest of Asia Pacific Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
54. Rest of Asia Pacific Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
55. Rest of Asia Pacific Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
56. Latin America Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
57. Latin America Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
58. Latin America Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
59. Latin America Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
60. Brazil Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
61. Brazil Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
62. Brazil Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
63. Brazil Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
64. Rest of Latin America Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
65. Rest of Latin America Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
66. Rest of Latin America Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
67. Rest of Latin America Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
68. The Middle East and Africa Recombinant Vaccines Market Revenue, by Type, 2016–2025 (USD Million)
69. The Middle East and Africa Recombinant Vaccines Market Revenue, by Application, 2016–2025 (USD Million)
70. The Middle East and Africa Recombinant Vaccines Market Revenue, by Disease, 2016–2025 (USD Million)
71. The Middle East and Africa Recombinant Vaccines Market Revenue, by Distribution Channel, 2016–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Recombinant vaccines are a type of vaccine that use genetic engineering to produce antigens that trigger an immune response without using the whole pathogen.
According to study, the Recombinant Vaccines Market size was worth around USD 10.15 billion in 2023 and is predicted to grow to around USD 26.61 billion by 2032.
The CAGR value of Recombinant Vaccines Market is expected to be around 11.3% during 2024-2032.
North America has been leading the Recombinant Vaccines Market and is anticipated to continue on the dominant position in the years to come.
The Recombinant Vaccines Market is led by players like Pfizer, Merck, Sanofi Pasteur, Bayer, GlaxoSmithKline, Serum Institute of India, Abiomed, Johnson & Johnson, Emergent Bio Solutions, and Mitsubishi Tanabe Pharma.
HappyClients
